Abstract
Several new drugs have been approved to treat rare genetic disorders: setmelanotide for certain conditions causing obesity; lumasiran for primary hyperoxaluria type 1, a kidney disorder; and lonafarnib for two diseases that cause premature aging.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have